Katherine Jean Aitchison, M.A. Ph.D. - Publications

Affiliations: 
Institute of Psychiatry, University of London, London, England, United Kingdom 
Area:
Genetics of mood disorders

121 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Ren H, Guan L, Zhao L, Lin Y, Wang Y, Yang Z, Li X, Ma X, Cheng X, Deng W, Aitchison KJ, Cao L, Li T. Contribution of genes in the GABAergic pathway to bipolar disorder and its executive function deficit in the Chinese Han population. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 29135068 DOI: 10.1002/ajmg.b.32601  0.36
2016 Trotta A, Iyegbe C, Di Forti M, Sham PC, Campbell DD, Cherny SS, Mondelli V, Aitchison KJ, Murray RM, Vassos E, Fisher HL. Interplay between Schizophrenia Polygenic Risk Score and Childhood Adversity in First-Presentation Psychotic Disorder: A Pilot Study. Plos One. 11: e0163319. PMID 27648571 DOI: 10.1371/journal.pone.0163319  1
2016 Iniesta R, Malki K, Maier W, Rietschel M, Mors O, Hauser J, Henigsberg N, Dernovsek MZ, Souery D, Stahl D, Dobson R, Aitchison KJ, Farmer A, Lewis CM, McGuffin P, et al. Combining clinical variables to optimize prediction of antidepressant treatment outcomes. Journal of Psychiatric Research. 78: 94-102. PMID 27089522 DOI: 10.1016/j.jpsychires.2016.03.016  1
2015 Hodgson K, Tansey KE, Powell TR, Coppola G, Uher R, Zvezdana Dernovšek M, Mors O, Hauser J, Souery D, Maier W, Henigsberg N, Rietschel M, Placentino A, Aitchison KJ, Craig IW, et al. Transcriptomics and the mechanisms of antidepressant efficacy. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26621261 DOI: 10.1016/j.euroneuro.2015.10.009  1
2015 Fu CH, Legge RM, Cohen-Woods S, Cole JH, Aitchison KJ, McGuffin P. Authors' reply. The British Journal of Psychiatry : the Journal of Mental Science. 207: 363-4. PMID 26429689 DOI: 10.1192/bjp.207.4.363a  1
2015 Rucker JJ, Tansey KE, Rivera M, Pinto D, Cohen-Woods S, Uher R, Aitchison KJ, Craddock N, Owen MJ, Jones L, Jones I, Korszun A, Barnes MR, Preisig M, Mors O, et al. Phenotypic Association Analyses with Copy Number Variation in Recurrent Depressive Disorder. Biological Psychiatry. PMID 25861698 DOI: 10.1016/j.biopsych.2015.02.025  1
2015 Colizzi M, Iyegbe C, Powell J, Ursini G, Porcelli A, Bonvino A, Taurisano P, Romano R, Masellis R, Blasi G, Morgan C, Aitchison K, Mondelli V, Luzi S, Kolliakou A, et al. Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis. Schizophrenia Bulletin. PMID 25829376 DOI: 10.1093/schbul/sbv032  1
2015 Hodgson K, Tansey KE, Uher R, Dernovšek MZ, Mors O, Hauser J, Souery D, Maier W, Henigsberg N, Rietschel M, Placentino A, Craig IW, Aitchison KJ, Farmer AE, Dobson RJ, et al. Exploring the role of drug-metabolising enzymes in antidepressant side effects. Psychopharmacology. 232: 2609-17. PMID 25761838 DOI: 10.1007/s00213-015-3898-x  1
2015 Legge RM, Sendi S, Cole JH, Cohen-Woods S, Costafreda SG, Simmons A, Farmer AE, Aitchison KJ, McGuffin P, Fu CH. Modulatory effects of brain-derived neurotrophic factor Val66Met polymorphism on prefrontal regions in major depressive disorder. The British Journal of Psychiatry : the Journal of Mental Science. 206: 379-84. PMID 25745134 DOI: 10.1192/bjp.bp.113.143529  1
2015 Ferentinos P, Koukounari A, Power R, Rivera M, Uher R, Craddock N, Owen MJ, Korszun A, Jones L, Jones I, Gill M, Rice JP, Ising M, Maier W, Mors O, ... ... Aitchison KJ, et al. Familiality and SNP heritability of age at onset and episodicity in major depressive disorder. Psychological Medicine. 1-11. PMID 25698070 DOI: 10.1017/S0033291715000215  1
2014 Vyas NS, Ahn K, Stahl DR, Caviston P, Simic M, Netherwood S, Puri BK, Lee Y, Aitchison KJ. Association of KIBRA rs17070145 polymorphism with episodic memory in the early stages of a human neurodevelopmental disorder. Psychiatry Research. 220: 37-43. PMID 25146696 DOI: 10.1016/j.psychres.2014.07.024  1
2014 Koola MM, Buchanan RW, Pillai A, Aitchison KJ, Weinberger DR, Aaronson ST, Dickerson FB. Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia. Schizophrenia Research. 157: 84-9. PMID 24878431 DOI: 10.1016/j.schres.2014.04.037  1
2014 Zhang JP, Aitchison KJ, Malhotra AK. The 12th Annual Pharmacogenetics in Psychiatry meeting report. Psychiatric Genetics. 24: 218-20. PMID 24859420 DOI: 10.1097/YPG.0000000000000041  1
2014 Hung CF, Rivera M, Craddock N, Owen MJ, Gill M, Korszun A, Maier W, Mors O, Preisig M, Rice JP, Rietschel M, Jones L, Middleton L, Aitchison KJ, Davis OS, et al. Relationship between obesity and the risk of clinically significant depression: Mendelian randomisation study. The British Journal of Psychiatry : the Journal of Mental Science. 205: 24-8. PMID 24809401 DOI: 10.1192/bjp.bp.113.130419  1
2014 Bernier D, Macintyre G, Bartha R, Hanstock CC, McAllindon D, Cox D, Purdon S, Aitchison KJ, Rusak B, Tibbo PG. NPAS3 variants in schizophrenia: a neuroimaging study. Bmc Medical Genetics. 15: 37. PMID 24674381 DOI: 10.1186/1471-2350-15-37  1
2014 Koola MM, Tsapakis EM, Wright P, Smith S, Kerwin Rip RW, Nugent KL, Aitchison KJ. Association of tardive dyskinesia with variation in CYP2D6: Is there a role for active metabolites? Journal of Psychopharmacology (Oxford, England). 28: 665-670. PMID 24595968 DOI: 10.1177/0269881114523861  1
2014 Rossolatos D, Aitchison KJ. Genomics for clinical utility: the future is near. Genome Medicine. 6: 3. PMID 24468134 DOI: 10.1186/gm522  1
2014 Tsapakis EM, Fernandes C, Moran-Gates T, Basu A, Sugden K, Aitchison KJ, Tarazi FI. Effects of antidepressant drug exposure on gene expression in the developing cerebral cortex. Synapse (New York, N.Y.). 68: 209-20. PMID 24458505 DOI: 10.1002/syn.21732  1
2014 Tansey KE, Rucker JJ, Kavanagh DH, Guipponi M, Perroud N, Bondolfi G, Domenici E, Evans DM, Hauser J, Henigsberg N, Jerman B, Maier W, Mors O, O'Donovan M, Peters TJ, ... ... Aitchison KJ, et al. Copy number variants and therapeutic response to antidepressant medication in major depressive disorder. The Pharmacogenomics Journal. 14: 395-9. PMID 24445990 DOI: 10.1038/tpj.2013.51  1
2014 Hodgson K, Uher R, Crawford AA, Lewis G, O'Donovan MC, Keers R, Dernovsek MZ, Mors O, Hauser J, Souery D, Maier W, Henigsberg N, Rietschel M, Placentino A, Aitchison K, et al. Genetic predictors of antidepressant side effects: a grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study. Journal of Psychopharmacology (Oxford, England). 28: 142-50. PMID 24414086 DOI: 10.1177/0269881113517957  1
2014 Hodgson K, Tansey K, Dernovsek MZ, Hauser J, Henigsberg N, Maier W, Mors O, Placentino A, Rietschel M, Souery D, Smith R, Craig IW, Farmer AE, Aitchison KJ, Belsy S, et al. Genetic differences in cytochrome P450 enzymes and antidepressant treatment response. Journal of Psychopharmacology (Oxford, England). 28: 133-41. PMID 24257813 DOI: 10.1177/0269881113512041  1
2013 Baldwin DS, Aitchison K, Bateson A, Curran HV, Davies S, Leonard B, Nutt DJ, Stephens DN, Wilson S. Benzodiazepines: risks and benefits. A reconsideration. Journal of Psychopharmacology (Oxford, England). 27: 967-71. PMID 24067791 DOI: 10.1177/0269881113503509  1
2013 Dominguez MD, Fisher HL, Major B, Chisholm B, Rahaman N, Joyce J, Woolley J, Lawrence J, Hinton M, Marlowe K, Aitchison K, Johnson S, Hodes M. Duration of untreated psychosis in adolescents: ethnic differences and clinical profiles. Schizophrenia Research. 150: 526-32. PMID 24025696 DOI: 10.1016/j.schres.2013.08.018  1
2013 Power RA, Cohen-Woods S, Ng MY, Butler AW, Craddock N, Korszun A, Jones L, Jones I, Gill M, Rice JP, Maier W, Zobel A, Mors O, Placentino A, Rietschel M, ... Aitchison KJ, et al. Genome-wide association analysis accounting for environmental factors through propensity-score matching: application to stressful live events in major depressive disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 162: 521-9. PMID 23857890 DOI: 10.1002/ajmg.b.32180  1
2013 Costafreda SG, McCann P, Saker P, Cole JH, Cohen-Woods S, Farmer AE, Aitchison KJ, McGuffin P, Fu CH. Modulation of amygdala response and connectivity in depression by serotonin transporter polymorphism and diagnosis. Journal of Affective Disorders. 150: 96-103. PMID 23643106 DOI: 10.1016/j.jad.2013.02.028  1
2013 Almandil NB, Liu Y, Murray ML, Besag FM, Aitchison KJ, Wong IC. Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis. Paediatric Drugs. 15: 139-50. PMID 23519708 DOI: 10.1007/s40272-013-0016-6  1
2013 Wolff K, Aitchison KJ. Reply to 'MDMA can increase cortical levels by 800% in dance clubbers' Parrott et al Journal of Psychopharmacology. 27: 115-116. PMID 23255437 DOI: 10.1177/0269881112455288  1
2013 Powell TR, Schalkwyk LC, Heffernan AL, Breen G, Lawrence T, Price T, Farmer AE, Aitchison KJ, Craig IW, Danese A, Lewis C, McGuffin P, Uher R, Tansey KE, D'Souza UM. Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1105-14. PMID 23142150 DOI: 10.1016/j.euroneuro.2012.09.009  1
2013 Cattaneo A, Gennarelli M, Uher R, Breen G, Farmer A, Aitchison KJ, Craig IW, Anacker C, Zunsztain PA, McGuffin P, Pariante CM. Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 377-85. PMID 22990943 DOI: 10.1038/npp.2012.191  1
2013 Ghali S, Fisher HL, Joyce J, Major B, Hobbs L, Soni S, Chisholm B, Rahaman N, Papada P, Lawrence J, Bloy S, Marlowe K, Aitchison KJ, Power P, Johnson S. Ethnic variations in pathways into early intervention services for psychosis. The British Journal of Psychiatry : the Journal of Mental Science. 202: 277-83. PMID 22955006 DOI: 10.1192/bjp.bp.111.097865  1
2013 Di Nicola M, Cattaneo A, Hepgul N, Di Forti M, Aitchison KJ, Janiri L, Murray RM, Dazzan P, Pariante CM, Mondelli V. Serum and gene expression profile of cytokines in first-episode psychosis. Brain, Behavior, and Immunity. 31: 90-5. PMID 22749891 DOI: 10.1016/j.bbi.2012.06.010  1
2013 Rucker JJ, Breen G, Pinto D, Pedroso I, Lewis CM, Cohen-Woods S, Uher R, Schosser A, Rivera M, Aitchison KJ, Craddock N, Owen MJ, Jones L, Jones I, Korszun A, et al. Genome-wide association analysis of copy number variation in recurrent depressive disorder. Molecular Psychiatry. 18: 183-9. PMID 22042228 DOI: 10.1038/mp.2011.144  1
2013 Uher R, Tansey KE, Rietschel M, Henigsberg N, Maier W, Mors O, Hauser J, Placentino A, Souery D, Farmer A, Aitchison KJ, Craig I, McGuffin P, Lewis CM, Ising M, et al. Common genetic variation and antidepressant efficacy in major depressive disorder: A meta-analysis of three genome-wide pharmacogenetic studies American Journal of Psychiatry. 170: 207-217. DOI: 10.1176/appi.ajp.2012.12020237  1
2012 Tansey KE, Guipponi M, Perroud N, Bondolfi G, Domenici E, Evans D, Hall SK, Hauser J, Henigsberg N, Hu X, Jerman B, Maier W, Mors O, O'Donovan M, Peters TJ, ... ... Aitchison KJ, et al. Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis. Plos Medicine. 9: e1001326. PMID 23091423 DOI: 10.1371/journal.pmed.1001326  1
2012 Power RA, Keers R, Ng MY, Butler AW, Uher R, Cohen-Woods S, Ising M, Craddock N, Owen MJ, Korszun A, Jones L, Jones I, Gill M, Rice JP, Hauser J, ... ... Aitchison KJ, et al. Dissecting the genetic heterogeneity of depression through age at onset. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 159: 859-68. PMID 22915352 DOI: 10.1002/ajmg.b.32093  1
2012 Keers R, Pedroso I, Breen G, Aitchison KJ, Nolan PM, Cichon S, Nöthen MM, Rietschel M, Schalkwyk LC, Fernandes C. Reduced anxiety and depression-like behaviours in the circadian period mutant mouse afterhours. Plos One. 7: e38263. PMID 22719873 DOI: 10.1371/journal.pone.0038263  1
2012 Cole J, Chaddock CA, Farmer AE, Aitchison KJ, Simmons A, McGuffin P, Fu CH. White matter abnormalities and illness severity in major depressive disorder. The British Journal of Psychiatry : the Journal of Mental Science. 201: 33-9. PMID 22576724 DOI: 10.1192/bjp.bp.111.100594  1
2012 Aitchison KJ, Reynolds GP. Special issue on Pharmacogenetics. Journal of Psychopharmacology (Oxford, England). 26: 333. PMID 22378768 DOI: 10.1177/0269881112439150  1
2012 Vyas NS, Shamsi SA, Malhotra AK, Aitchison KJ, Kumari V. Can genetics inform the management of cognitive deficits in schizophrenia? Journal of Psychopharmacology (Oxford, England). 26: 334-48. PMID 22328662 DOI: 10.1177/0269881111434623  1
2012 Aitchison KJ, Tsapakis EM, Huezo-Diaz P, Kerwin RW, Forsling ML, Wolff K. Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT. Journal of Psychopharmacology (Oxford, England). 26: 408-18. PMID 22303032 DOI: 10.1177/0269881111434624  1
2012 Wolff K, Tsapakis EM, Pariante CM, Kerwin RW, Forsling ML, Aitchison KJ. Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption. Journal of Psychopharmacology (Oxford, England). 26: 419-28. PMID 21969106 DOI: 10.1177/0269881111415737  1
2012 Uher R, Perlis RH, Henigsberg N, Zobel A, Rietschel M, Mors O, Hauser J, Dernovsek MZ, Souery D, Bajs M, Maier W, Aitchison KJ, Farmer A, McGuffin P. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychological Medicine. 42: 967-80. PMID 21929846 DOI: 10.1017/S0033291711001905  1
2012 Huezo-Diaz P, Perroud N, Spencer EP, Smith R, Sim S, Virding S, Uher R, Gunasinghe C, Gray J, Campbell D, Hauser J, Maier W, Marusic A, Rietschel M, Perez J, ... ... Aitchison KJ, et al. CYP2C19 genotype predicts steady state escitalopram concentration in GENDEP. Journal of Psychopharmacology (Oxford, England). 26: 398-407. PMID 21926427 DOI: 10.1177/0269881111414451  1
2012 Rivera M, Cohen-Woods S, Kapur K, Breen G, Ng MY, Butler AW, Craddock N, Gill M, Korszun A, Maier W, Mors O, Owen MJ, Preisig M, Bergmann S, Tozzi F, ... ... Aitchison KJ, et al. Depressive disorder moderates the effect of the FTO gene on body mass index. Molecular Psychiatry. 17: 604-11. PMID 21502950 DOI: 10.1038/mp.2011.45  1
2012 Perroud N, Uher R, Ng MY, Guipponi M, Hauser J, Henigsberg N, Maier W, Mors O, Gennarelli M, Rietschel M, Souery D, Dernovsek MZ, Stamp AS, Lathrop M, Farmer A, ... ... Aitchison KJ, et al. Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project. The Pharmacogenomics Journal. 12: 68-77. PMID 20877300 DOI: 10.1038/tpj.2010.70  1
2012 Tsapakis EM, Curran S, Ohlsen RI, Vyas NS, Aitchison KJ, Daly AK. Pharmacogenetics in Psychiatry Pharmacogenetics and Individualized Therapy. 215-250. DOI: 10.1002/9781118116494.ch7  1
2011 Uher R, Mors O, Rietschel M, Rajewska-Rager A, Petrovic A, Zobel A, Henigsberg N, Mendlewicz J, Aitchison KJ, Farmer A, McGuffin P. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study. The Journal of Clinical Psychiatry. 72: 1478-84. PMID 22127194 DOI: 10.4088/JCP.10m06419  1
2011 Binder E, Malki K, Paya-Cano JL, Fernandes C, Aitchison KJ, Mathé AA, Sluyter F, Schalkwyk LC. Antidepressants and the resilience to early-life stress in inbred mouse strains. Pharmacogenetics and Genomics. 21: 779-89. PMID 22016050 DOI: 10.1097/FPC.0b013e32834b3f35  1
2011 Schosser A, Butler AW, Ising M, Perroud N, Uher R, Ng MY, Cohen-Woods S, Craddock N, Owen MJ, Korszun A, Jones L, Jones I, Gill M, Rice JP, Maier W, ... ... Aitchison KJ, et al. Genomewide association scan of suicidal thoughts and behaviour in major depression. Plos One. 6: e20690. PMID 21750702 DOI: 10.1371/journal.pone.0020690  1
2011 Mondelli V, Cattaneo A, Belvederi Murri M, Di Forti M, Handley R, Hepgul N, Miorelli A, Navari S, Papadopoulos AS, Aitchison KJ, Morgan C, Murray RM, Dazzan P, Pariante CM. Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume. The Journal of Clinical Psychiatry. 72: 1677-84. PMID 21672499 DOI: 10.4088/JCP.10m06745  1
2011 Uher R, Dernovsek MZ, Mors O, Hauser J, Souery D, Zobel A, Maier W, Henigsberg N, Kalember P, Rietschel M, Placentino A, Mendlewicz J, Aitchison KJ, McGuffin P, Farmer A. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. Journal of Affective Disorders. 132: 112-20. PMID 21411156 DOI: 10.1016/j.jad.2011.02.014  1
2011 Strohmaier J, Wüst S, Uher R, Henigsberg N, Mors O, Hauser J, Souery D, Zobel A, Dernovsek MZ, Streit F, Schmäl C, Kozel D, Placentino A, Farmer A, McGuffin P, ... Aitchison KJ, et al. Sexual dysfunction during treatment with serotonergic and noradrenergic antidepressants: clinical description and the role of the 5-HTTLPR. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 12: 528-38. PMID 21388237 DOI: 10.3109/15622975.2011.559270  1
2011 Aitchison KJ, Malhotra AK. The Ninth Annual Pharmacogenetics in Psychiatry Meeting report. Psychiatric Genetics. 21: 112-3. PMID 21206402 DOI: 10.1097/YPG.0b013e328341e07e  1
2011 Keers R, Aitchison KJ. Pharmacogenetics of antidepressant response. Expert Review of Neurotherapeutics. 11: 101-25. PMID 21158559 DOI: 10.1586/ern.10.186  1
2011 Malki K, Uher R, Paya-Cano J, Binder E, Rietschel M, Zobel A, Mors O, Hauser J, Henigsberg N, Jerman B, Souery D, Placentino A, Ng MY, Cohen-Woods S, Sluyter F, ... ... Aitchison KJ, et al. Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants. Biological Psychiatry. 69: 360-5. PMID 20970119 DOI: 10.1016/j.biopsych.2010.08.011  1
2011 Keers R, Bonvicini C, Scassellati C, Uher R, Placentino A, Giovannini C, Rietschel M, Henigsberg N, Kozel D, Mors O, Maier W, Hauser J, Souery D, Mendlewicz J, Schmäl C, ... ... Aitchison KJ, et al. Variation in GNB3 predicts response and adverse reactions to antidepressants. Journal of Psychopharmacology (Oxford, England). 25: 867-74. PMID 20826553 DOI: 10.1177/0269881110376683  1
2011 Uher R, Mors O, Hauser J, Rietschel M, Maier W, Kozel D, Henigsberg N, Souery D, Placentino A, Keers R, Gray JM, Dernovsek MZ, Strohmaier J, Larsen ER, Zobel A, ... ... Aitchison KJ, et al. Changes in body weight during pharmacological treatment of depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 367-75. PMID 20716398 DOI: 10.1017/S1461145710000933  1
2011 Aas M, Dazzan P, Mondelli V, Toulopoulou T, Reichenberg A, Di Forti M, Fisher HL, Handley R, Hepgul N, Marques T, Miorelli A, Taylor H, Russo M, Wiffen B, Papadopoulos A, ... Aitchison KJ, et al. Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis. Psychological Medicine. 41: 463-76. PMID 20529412 DOI: 10.1017/S0033291710001170  1
2011 Keers R, Uher R, Huezo-Diaz P, Smith R, Jaffee S, Rietschel M, Henigsberg N, Kozel D, Mors O, Maier W, Zobel A, Hauser J, Souery D, Placentino A, Larsen ER, ... ... Aitchison KJ, et al. Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project. The Pharmacogenomics Journal. 11: 138-45. PMID 20212518 DOI: 10.1038/tpj.2010.14  1
2011 Aitchison KJ, Mir A, Shivakumar K, McAllister VD, O'Keane V, McCrone P. Costs and outcomes associated with an aripiprazole add-on or switching open-label study in psychosis. Journal of Psychopharmacology (Oxford, England). 25: 675-84. PMID 20176773 DOI: 10.1177/0269881109358198  1
2010 Drago A, Serretti A, Smith R, Huezo-Diaz P, Malitas P, Albani D, Ronchi DD, Pae CU, Aitchison KJ. No association between genetic markers in BDNF gene and lithium prophylaxis in a Greek sample. International Journal of Psychiatry in Clinical Practice. 14: 154-7. PMID 24922477 DOI: 10.3109/13651501003706717  1
2010 Keers R, Aitchison KJ. Gender differences in antidepressant drug response. International Review of Psychiatry (Abingdon, England). 22: 485-500. PMID 21047161 DOI: 10.3109/09540261.2010.496448  1
2010 Keers R, Uher R, Gupta B, Rietschel M, Schulze TG, Hauser J, Skibinska M, Henigsberg N, Kalember P, Maier W, Zobel A, Mors O, Kristensen AS, Kozel D, Giovannini C, ... ... Aitchison KJ, et al. Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP. Journal of Affective Disorders. 127: 337-42. PMID 20609482 DOI: 10.1016/j.jad.2010.06.011  1
2010 Lewis CM, Ng MY, Butler AW, Cohen-Woods S, Uher R, Pirlo K, Weale ME, Schosser A, Paredes UM, Rivera M, Craddock N, Owen MJ, Jones L, Jones I, Korszun A, ... Aitchison KJ, et al. Genome-wide association study of major recurrent depression in the U.K. population. The American Journal of Psychiatry. 167: 949-57. PMID 20516156 DOI: 10.1176/appi.ajp.2010.09091380  1
2010 McGuffin P, Perroud N, Uher R, Butler A, Aitchison KJ, Craig I, Lewis C, Farmer A. The genetics of affective disorder and suicide. European Psychiatry : the Journal of the Association of European Psychiatrists. 25: 275-7. PMID 20462744 DOI: 10.1016/j.eurpsy.2009.12.012  1
2010 Uher R, Perroud N, Ng MY, Hauser J, Henigsberg N, Maier W, Mors O, Placentino A, Rietschel M, Souery D, Zagar T, Czerski PM, Jerman B, Larsen ER, Schulze TG, ... ... Aitchison KJ, et al. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. The American Journal of Psychiatry. 167: 555-64. PMID 20360315 DOI: 10.1176/appi.ajp.2009.09070932  1
2010 Mondelli V, Pariante CM, Navari S, Aas M, D'Albenzio A, Di Forti M, Handley R, Hepgul N, Marques TR, Taylor H, Papadopoulos AS, Aitchison KJ, Murray RM, Dazzan P. Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis. Schizophrenia Research. 119: 75-8. PMID 20071148 DOI: 10.1016/j.schres.2009.12.021  1
2010 Su KP, Huang SY, Peng CY, Lai HC, Huang CL, Chen YC, Aitchison KJ, Pariante CM. Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels. Biological Psychiatry. 67: 550-7. PMID 20034614 DOI: 10.1016/j.biopsych.2009.11.005  1
2010 Uher R, Muthén B, Souery D, Mors O, Jaracz J, Placentino A, Petrovic A, Zobel A, Henigsberg N, Rietschel M, Aitchison KJ, Farmer A, McGuffin P. Trajectories of change in depression severity during treatment with antidepressants. Psychological Medicine. 40: 1367-77. PMID 19863842 DOI: 10.1017/S0033291709991528  1
2010 Perroud N, Uher R, Hauser J, Rietschel M, Henigsberg N, Placentino A, Kozel D, Maier W, Mors O, Souery D, Dmitrzak-Weglarz M, Jorgensen L, Kovacic Z, Giovannini C, Mendlewicz J, ... ... Aitchison KJ, et al. History of suicide attempts among patients with depression in the GENDEP project. Journal of Affective Disorders. 123: 131-7. PMID 19772940 DOI: 10.1016/j.jad.2009.09.001  1
2010 Mondelli V, Dazzan P, Hepgul N, Di Forti M, Aas M, D'Albenzio A, Di Nicola M, Fisher H, Handley R, Marques TR, Morgan C, Navari S, Taylor H, Papadopoulos A, Aitchison KJ, et al. Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment. Schizophrenia Research. 116: 234-42. PMID 19751968 DOI: 10.1016/j.schres.2009.08.013  1
2010 Aitchison K, Datla K, Rooprai H, Fernando J, Dexter D. Regional distribution of clomipramine and desmethylclomipramine in rat brain and peripheral organs on chronic clomipramine administration. Journal of Psychopharmacology (Oxford, England). 24: 1261-8. PMID 19553387 DOI: 10.1177/0269881109105789  1
2010 Sugden K, Pariante CM, McGuffin P, Aitchison KJ, D'Souza UM. Housekeeping gene expression is affected by antidepressant treatment in a mouse fibroblast cell line. Journal of Psychopharmacology (Oxford, England). 24: 1253-9. PMID 19074533 DOI: 10.1177/0269881108099690  1
2010 Keers R, Farmer AE, Aitchison KJ. The authors reply Psychological Medicine. 40: 702-704. DOI: 10.1017/S0033291710000012  1
2009 Aitchison K, Serretti A, Goldman D, Curran S, Drago A, Malhotra AK. The 8th annual pharmacogenetics in psychiatry meeting report Pharmacogenomics Journal. 9: 358-361. PMID 19841640 DOI: 10.1038/tpj.2009.47  1
2009 Perroud N, Uher R, Marusic A, Rietschel M, Mors O, Henigsberg N, Hauser J, Maier W, Souery D, Placentino A, Szczepankiewicz A, Jorgensen L, Strohmaier J, Zobel A, Giovannini C, ... ... Aitchison KJ, et al. Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial. Bmc Medicine. 7: 60. PMID 19832967 DOI: 10.1186/1741-7015-7-60  1
2009 Aitchison KJ. Disclosure of religious beliefs. The British Journal of Psychiatry : the Journal of Mental Science. 195: 368; author reply 36. PMID 19794209 DOI: 10.1192/bjp.195.4.368b  1
2009 Uher R, Farmer A, Henigsberg N, Rietschel M, Mors O, Maier W, Kozel D, Hauser J, Souery D, Placentino A, Strohmaier J, Perroud N, Zobel A, Rajewska-Rager A, Dernovsek MZ, ... ... Aitchison KJ, et al. Adverse reactions to antidepressants. The British Journal of Psychiatry : the Journal of Mental Science. 195: 202-10. PMID 19721108 DOI: 10.1192/bjp.bp.108.061960  1
2009 Perroud N, Aitchison KJ, Uher R, Smith R, Huezo-Diaz P, Marusic A, Maier W, Mors O, Placentino A, Henigsberg N, Rietschel M, Hauser J, Souery D, Kapelski P, Bonvicini C, et al. Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2517-28. PMID 19641488 DOI: 10.1038/npp.2009.81  1
2009 Huezo-Diaz P, Uher R, Smith R, Rietschel M, Henigsberg N, Marusic A, Mors O, Maier W, Hauser J, Souery D, Placentino A, Zobel A, Larsen ER, Czerski PM, Gupta B, ... ... Aitchison KJ, et al. Moderation of antidepressant response by the serotonin transporter gene. The British Journal of Psychiatry : the Journal of Mental Science. 195: 30-8. PMID 19567893 DOI: 10.1192/bjp.bp.108.062521  1
2009 Uher R, Huezo-Diaz P, Perroud N, Smith R, Rietschel M, Mors O, Hauser J, Maier W, Kozel D, Henigsberg N, Barreto M, Placentino A, Dernovsek MZ, Schulze TG, Kalember P, ... ... Aitchison KJ, et al. Genetic predictors of response to antidepressants in the GENDEP project. The Pharmacogenomics Journal. 9: 225-33. PMID 19365399 DOI: 10.1038/tpj.2009.12  1
2009 Uher R, Mors O, Hauser J, Rietschel M, Maier W, Kozel D, Henigsberg N, Souery D, Placentino A, Perroud N, Dernovsek MZ, Strohmaier J, Larsen ER, Zobel A, Leszczynska-Rodziewicz A, ... ... Aitchison KJ, et al. Body weight as a predictor of antidepressant efficacy in the GENDEP project. Journal of Affective Disorders. 118: 147-54. PMID 19269691 DOI: 10.1016/j.jad.2009.02.013  1
2009 Uher R, Maier W, Hauser J, Marusic A, Schmael C, Mors O, Henigsberg N, Souery D, Placentino A, Rietschel M, Zobel A, Dmitrzak-Weglarz M, Petrovic A, Jorgensen L, Kalember P, ... ... Aitchison KJ, et al. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. The British Journal of Psychiatry : the Journal of Mental Science. 194: 252-9. PMID 19252156 DOI: 10.1192/bjp.bp.108.057554  1
2009 Keers R, Farmer AE, Aitchison KJ. Extracting a needle from a haystack: reanalysis of whole genome data reveals a readily translatable finding. Psychological Medicine. 39: 1231-5. PMID 19215628 DOI: 10.1017/S0033291708005084  1
2009 Aitchison KJ, Bienroth M, Cookson J, Gray R, Haddad PM, Moore B, Ratna L, Sullivan G, Taylor D, Taylor M, Goodwin GM. A UK consensus on the administration of aripiprazole for the treatment of mania. Journal of Psychopharmacology (Oxford, England). 23: 231-40. PMID 19010974 DOI: 10.1177/0269881108098820  1
2009 Bull SJ, Huezo-Diaz P, Binder EB, Cubells JF, Ranjith G, Maddock C, Miyazaki C, Alexander N, Hotopf M, Cleare AJ, Norris S, Cassidy E, Aitchison KJ, Miller AH, Pariante CM. Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Molecular Psychiatry. 14: 1095-104. PMID 18458677 DOI: 10.1038/mp.2008.48  1
2009 Aitchison KJ, McGuffin P. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression (British Journal of Psychiatry 194, (252-259)) British Journal of Psychiatry. 195: 87. DOI: 10.1192/bjp.195.1.87a  1
2008 Fisher H, Theodore K, Power P, Chisholm B, Fuller J, Marlowe K, Aitchison KJ, Tanna R, Joyce J, Sacks M, Craig T, Johnson S. Routine evaluation in first episode psychosis services: feasibility and results from the MiData project. Social Psychiatry and Psychiatric Epidemiology. 43: 960-7. PMID 18560782 DOI: 10.1007/s00127-008-0386-1  1
2008 Ohlsen RI, Williamson R, Yusufi B, Mullan J, Irving D, Mukherjee S, Page E, Aitchison KJ, Barnes TR. Interrater reliability of the Antipsychotic Non-Neurological Side-Effects Rating Scale measured in patients treated with clozapine. Journal of Psychopharmacology (Oxford, England). 22: 323-9. PMID 18541627 DOI: 10.1177/0269881108091069  1
2008 Mir A, Shivakumar K, Williamson RJ, McAllister V, O'Keane V, Aitchison KJ. Change in sexual dysfunction with aripiprazole: a switching or add-on study. Journal of Psychopharmacology (Oxford, England). 22: 244-53. PMID 18308789 DOI: 10.1177/0269881107082901  1
2008 Uher R, Farmer A, Maier W, Rietschel M, Hauser J, Marusic A, Mors O, Elkin A, Williamson RJ, Schmael C, Henigsberg N, Perez J, Mendlewicz J, Janzing JG, Zobel A, ... ... Aitchison KJ, et al. Measuring depression: comparison and integration of three scales in the GENDEP study. Psychological Medicine. 38: 289-300. PMID 17922940 DOI: 10.1017/S0033291707001730  1
2008 Cratsley K, Regan J, Mcallister V, Simic M, Aitchison KJ. Duration of untreated psychosis, referral route, and age of onset in an early intervention in psychosis service and a local CAMHS Child and Adolescent Mental Health. 13: 130-133. DOI: 10.1111/j.1475-3588.2007.00467.x  1
2008 Evangelia TM, Aitchison KJ. Biological treatments: General considerations Essential Psychiatry, Fourth Edition. 567-585. DOI: 10.1017/CBO9780511544125.026  1
2008 Tandon K, Aitchison KJ. Genetic Approaches to Depression: Association Studies Biology of Depression: From Novel Insights to Therapeutic Strategies. 757-795. DOI: 10.1002/9783527619672.ch31  1
2008 Romeo R, Aitchison KJ, Capdevielle D. Pharmacogenetic testing in psychiatry: Pharmacoeconomic applications and considerations Clinical Neuropsychiatry. 5: 206-211.  1
2008 McCrone P, Aitchison KJ, Taylor D. How far have we got in pharmacoeconomics for psychiatry and where are we going? Clinical Neuropsychiatry. 5: 173-174.  1
2008 Ohlsen RI, Taylor D, Tandon K, Aitchison KJ. Returning to the issue of the cost-effectiveness of antipsychotics in the treatment of Schizophrenia Clinical Neuropsychiatry. 5: 184-194.  1
2006 Wolff K, Tsapakis EM, Winstock AR, Hartley D, Holt D, Forsling ML, Aitchison KJ. Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population. Journal of Psychopharmacology (Oxford, England). 20: 400-10. PMID 16574714 DOI: 10.1177/0269881106061514  1
2006 Shivakumar K, Mir A, McAllister VDM, O'Keane V, Aitchison KJ. Aripiprazole in psychotic depression: Four case reports Clinical Neuropsychiatry. 3: 332-337.  1
2005 Howes OD, Smith S, Aitchison KJ. Comments on "Prolactin levels and erectile function in patients treated with risperidone" (J Clin Psychopharmacol 2004;24:161-166). Journal of Clinical Psychopharmacology. 25: 393-4. PMID 16012288 DOI: 10.1097/01.jcp.0000170033.78060.84  1
2005 Huezo-Diaz P, Tandon K, Aitchison KJ. The genetics of depression and related traits. Current Psychiatry Reports. 7: 117-24. PMID 15802088  1
2005 Aitchison KJ, Basu A, McGuffin P, Craig I. Psychiatry and the 'new genetics': hunting for genes for behaviour and drug response. The British Journal of Psychiatry : the Journal of Mental Science. 186: 91-2. PMID 15684228 DOI: 10.1192/bjp.186.2.91  1
2005 Basu A, Aitchison KJ. Pharmacogenetics: antidepressant drug response Psychiatry. 4: 30-34. DOI: 10.1383/psyt.2005.4.12.30  1
2004 Howes OD, Smith S, Aitchison KJ. Comment on Hyperprolactinaemia and antipsychotic therapy in schizophrenia. Current Medical Research and Opinion. 20: 1649. PMID 15462698 DOI: 10.1185/030079904X4941  1
2004 Tsapakis EM, Basu A, Aitchison KJ. Clinical relevance of discoveries in psychopharmacogenetics Advances in Psychiatric Treatment. 10: 455-465. DOI: 10.1192/apt.10.6.455  1
2001 Aitchison KJ, Zhao JH, Munro J, Collier DA, Makoff AJ, Kerwin RW. Investigation of an association between a CYP1A2 5′ flanking SNP (T-3591G) and response to clozapine American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 582.  1
2000 Aitchison KJ, Jann MW, Zhao JH, Sakai T, Zaher H, Wolff K, Collier DA, Kerwin RW, Gonzalez FJ. Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2-null mice. Journal of Psychopharmacology (Oxford, England). 14: 353-9. PMID 11198052  1
2000 Aitchison KJ, Gonzalez FJ, Quattrochi LC, Sapone A, Zhao JH, Zaher H, Elizondo G, Bryant C, Munro J, Collier DA, Makoffa AI, Kerwin RW. Identification of novel polymorphisms in the 5' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance. Pharmacogenetics. 10: 695-704. PMID 11186132 DOI: 10.1097/00008571-200011000-00004  1
2000 Aitchison KJ, Jordan BD, Sharma T. The relevance of ethnic influences on pharmacogenetics to the treatment of psychosis. Drug Metabolism and Drug Interactions. 16: 15-38. PMID 10820581  1
2000 Makoff AJ, Graham JM, Arranz MJ, Forsyth J, Li T, Aitchison KJ, Shaikh S, Grünewald RA. Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease. Pharmacogenetics. 10: 43-8. PMID 10739171 DOI: 10.1097/00008571-200002000-00006  1
1999 Aitchison KJ, Munro J, Wright P, Smith S, Makoff AJ, Sachse C, Sham PC, Murray RM, Collier DA, Kerwin RW. Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation. British Journal of Clinical Pharmacology. 48: 388-94. PMID 10510151 DOI: 10.1046/j.1365-2125.1999.00006.x  1
1999 Li T, Liu X, Sham PC, Aitchison KJ, Cai G, Arranz MJ, Deng H, Liu J, Kirov G, Murray RM, Collier DA. Association analysis between dopamine receptor genes and bipolar affective disorder. Psychiatry Research. 86: 193-201. PMID 10482338 DOI: 10.1016/S0165-1781(99)00034-7  1
1999 Taylor D, Aitchison KJ. The pharmaco-economics of atypical antipsychotics International Journal of Psychiatry in Clinical Practice. 3: 237-248.  1
1998 Li T, Arranz M, Aitchison KJ, Bryant C, Liu X, Kerwin RW, Murray R, Sham P, Collier DA. Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophrenia. Schizophrenia Research. 32: 87-92. PMID 9713903 DOI: 10.1016/S0920-9964(98)00024-3  1
1998 Holmes C, Russ C, Kirov G, Aitchison KJ, Powell JF, Collier DA, Lovestone S. Apolipoprotein E: depressive illness, depressive symptoms, and Alzheimer's disease. Biological Psychiatry. 43: 159-64. PMID 9494696 DOI: 10.1016/S0006-3223(97)00326-0  1
1997 Kerwin RW, Aitchison KJ. Cost-effectiveness of clozapine. The British Journal of Psychiatry : the Journal of Mental Science. 171: 584. PMID 9519106  1
1997 Aitchison KJ, Kerwin RW. Cost-effectiveness of clozapine. A UK clinic-based study. The British Journal of Psychiatry : the Journal of Mental Science. 171: 125-30. PMID 9337946  1
1997 Kunugi H, Vallada HP, Hoda F, Kirov G, Gill M, Aitchison KJ, Ball D, Arranz MJ, Murray RM, Collier DA. No evidence for an association of affective disorders with high- or low-activity allele of catechol-o-methyltransferase gene. Biological Psychiatry. 42: 282-5. PMID 9270905 DOI: 10.1016/S0006-3223(96)00366-6  1
1996 Hoda F, Nicholl D, Bennett P, Arranz M, Aitchison KJ, al-Chalabi A, Kunugi H, Vallada H, Leigh PN, Chaudhuri KR, Collier DA. No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase. Biochemical and Biophysical Research Communications. 228: 780-4. PMID 8941353 DOI: 10.1006/bbrc.1996.1731  1
1996 Collier DA, Arranz MJ, Sham P, Battersby S, Vallada H, Gill P, Aitchison KJ, Sodhi M, Li T, Roberts GW, Smith B, Morton J, Murray RM, Smith D, Kirov G. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neuroreport. 7: 1675-9. PMID 8904780  1
1996 Sodhi MS, Arranz MJ, Kirov G, Ball DM, Aitchison KJ, Abusaad I, Kerwin RW, Collier DA. Association between psychoses and allelic variation in 5-HT2A and 5-HT2C receptor genes British Journal of Clinical Pharmacology. 41: 457P.  1
Show low-probability matches.